CELLULAR tests
-
NEUROFIT offers a large range of models and assays for evaluating neurotoxicity, neuroprotection or neurotrophic activity of new test compounds.
We develop custom protocols to determine mechanism of action, or define therapeutic indication of new drug candidates.
DEPRESSION
Today, growing interest has shifted to the reactivation of a juvenile-like plasticity in the brain for the treatment of depression.
To be in line with this development concept, NEUROFIT proposes neuronal neurite outgrowth assay to demonstrate the effect of your antidepressant compounds.
-
Effect of reference compounds on neurite outgrowth in cortical neurons culture.
-
Human iPSC Neurons-based screening to evaluate the capability of test compound to promote dendrite formation and growth.